首页> 外国专利> Method for screening anti-cervical cancer agents and anti-apoptotic modulating agents

Method for screening anti-cervical cancer agents and anti-apoptotic modulating agents

机译:筛选抗宫颈癌药物和抗凋亡调节剂的方法

摘要

The invention papil person causing cervical cancer by the present invention using the transformant Escherichia coli BL21 / pET28a-E6 (E.coli BL21 / pET28a-E6) KCTC 18015P relates to cervical cancer and apoptosis regulators search method Roman E6 protein of the virus type 16 (His-16 E6) a mass expression and a cost-soluble His-16 E6 protein purified using nickel beads after, E6- binding proteins involved in the ubiquitin (ubiquitin) reaction (E6- associated protein; a bond with the soluble fraction of the E6AP) by identifying a Western blotting method and Ella and (ELISA) method in vitro, and the excellent effect of establishing the E6-E6AP in vitro binding capacity search system E6-E6AP coupled to the search system the screening of synthetic peptide capable of competitively inhibiting and variations, cell run, which can be screened for anticancer drug design based on the combined navigation and E6-p53 binding structure of apoptosis regulators I have worked.
机译:通过本发明,使用转化子大肠杆菌 BL21 / pET28a-E6(大肠杆菌BL21 / pET28a-E6)KCTC 18015P的发明宫颈癌的宫颈癌和凋亡调节剂的检索方法16型病毒的E6蛋白(His-16 E6)的表达和成本可溶的His-16 E6蛋白用镍珠纯化后,参与遍在蛋白(ubiquitin)反应的E6-结合蛋白(E6相关蛋白; (I)在体外鉴定蛋白质印迹法,Ella和(ELISA)方法,以及在体外建立E6-E6AP 的优异效果 I>结合能力搜索系统E6-E6AP与搜索系统结合,筛选出具有竞争性抑制和变异,细胞运行的合成肽,可以基于组合的导航和细胞凋亡的E6-p53结合结构来筛选抗癌药物设计我曾经工作过的监管者。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号